Sanofi processes your personal data in the context of the performance of the Type 1 Diabetes (T1D) Innovation Grant Program. This processing includes the identification and the selection of Healthcare Professionals or Scientific external experts regarding innovative projects addressing novel autoimmune pathways, early detection approaches, biomarker strategies, and AI and machine learning applications.
You have the right to access, rectify, or delete your data, withdraw your consent, to object, to or restrict its processing or to ask for a copy of your personal data in a readable digital format. You can contact us anytime to exercise your rights.
For more details on how Sanofi handles your personal data, please consult the Privacy notice in attachment.